NCT00421148View on ClinicalTrials.gov

Dose-Finding Pediatric and Adult Trial With Sugammadex (Org 25969, MK-8616, SCH 900616) (19.4.306) (MK-8616-034) (P05961)

PHASE3CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

May 30, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

June 2, 2006

Conditions
Anesthesia
Interventions
DRUG

Sugammadex 0.5 mg/kg

IV infusion

DRUG

Sugammadex 1 mg/kg

IV infusion

DRUG

Sugammadex 2 mg/kg

IV infusion

DRUG

Sugammadex 4 mg/kg

IV infusion

DRUG

Placebo

IV infusion

DRUG

Rocuronium bromide

IV infusion

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00421148 - Dose-Finding Pediatric and Adult Trial With Sugammadex (Org 25969, MK-8616, SCH 900616) (19.4.306) (MK-8616-034) (P05961) | Biotech Hunter | Biotech Hunter